Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Opioid Policy topic
No spam. Unsubscribe anytime.
House unanimously passes bill requiring prescribers to discuss opioid risks before initial prescriptions
Summary
HB191 would require prescribers to discuss addiction and overdose risks, alternatives, and drug interactions with patients before issuing an initial opioid prescription; sponsors said it is intended to reduce new addictions and complements Naloxone efforts. (House vote: 67–0)
Representative Lisonbee, sponsor of House Bill 191, described the measure as a modest, upstream step to reduce opioid misuse by requiring a prescriber to discuss risks of addiction, alternative pain treatments and dangers of mixing opioids with alcohol or benzodiazepines before an initial opioid prescription. She said the requirement does not apply to hospice or chronic pain patients and does not impose documentation requirements on providers.
Lawmakers who spoke in support recounted personal and constituent experiences of prescriptions leading to misuse. Representative Coleman described a family case in which a relative obtained opioids despite a prior "do not prescribe" instruction from a primary-care team; other speakers said the bill strikes a balance between preventing addiction and avoiding burdensome paperwork for providers.
Representative Eliason, in summation, said that 80 percent of Utahns who die of overdose began with a prescription opioid and urged the House to approve the upstream measure. The House passed first substitute HB191 67–0 and transmitted it to the Senate for consideration.
The bill establishes a conversation requirement; it does not create an enforcement mechanism or require electronic-medical-record documentation, according to the sponsor’s floor remarks.
